How do I buy Amgen (AMGN) stock?

Buying Amgen (AMGN) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "AMGN", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy AMGN by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

How do I tell if AMGN is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Amgen (AMGN) Stock

Q: What is the minimum investment for AMGN on Gotrade?

On Gotrade , you don't have to buy a full lot. With fractional shares, you can start investing in Amgen from just $1. A small budget shouldn't stop you from building a US stock portfolio.

NASDAQ · AMGN

Trade AMGN

Key stats

Market cap: $249.37B
Price / Earnings ratio: 28.5x
EPS (TTM): $16.22
Volume: Loading
52-week high: $475.65
52-week low: $294.48
Dividend yield: 2.08%
Dividend amount (latest): $2.52
EPS vs analyst estimate: +12.6%Q3 FY25 · $5.64 vs $5.01

Source: third-party data provider, as of November 5, 2026

EPS estimate: analyst consensus

Compare with AMGN

Technical indicators

RSI 14: 73.40
MACD 12/26/9: 14.79
EMA 9 of MACD: 11.73
MACD histogram: 3.07
SMA 50: $421.56; Price above SMA 50
EMA 50: $425.71; Price above EMA 50
SMA 200: $376.86; Price above SMA 200
EMA 200: $381.68; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of November 4, 2026. Technical data, not a recommendation.

Analyst ratings

Analyst consensus: Hold

Based on 21 analyst ratings

Strong Sell0

Sell0

Hold13

Buy8

Strong Buy0

Third-party analyst opinion, not a recommendation from Gotrade.

Financials

Performance

Revenue

Net income

Net margin %

2021

2022

2023

2025

44B29B15B0

Debt & Balance Sheet

Total assets

Total liabilities

2021

2022

2023

2025

117B77B38B0

Revenue to Profit

2025

$36.8B

Revenue

$0.0

Cost of revenue

$24.7B

Gross profit

$0.0

Operating expenses

$7.7B

Net income

Earnings

EPS forecast

Actual EPS

$5.64

$5.01

Q3FY25

$4.74

Q4FY25

$4.93

Q1FY26

$5.67

Q2FY26

$5.63

Q3FY26

The market is expecting earnings per share of $5.63 for this quarter. The company has not yet shared when it is announcing earnings.

Source: third-party data provider

About Amgen

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives.

SectorHealthcare

IndustryDrug Manufacturers - General

Employees31,500

CEOMr. Robert A. Bradway

IPO DateJun 17, 1983

HeadquartersThousand Oaks, CA

Key Executives

Name	Title	Year Born
Mr. Robert A. Bradway	Chairman & CEO	1963
Mr. Thomas J. W. Dittrich	Executive VP & CFO	1964
Mr. Murdo Gordon	Executive Vice President of Global Markets and Policy	1967
Mr. Peter H. Griffith	Executive Vice President	1959
Dr. James E. Bradner M.D.	EVP of Research & Development, Artificial Intelligence and Data	1972
Mr. Esteban Santos	Executive Vice President of Operations	1968
Mr. Matthew C. Busch	Chief Accounting Officer & VP of Finance	1975
Mr. Sean Bruich	SVP & Chief Technology Officer	—
Mr. Scott Skellenger	Senior VP & Chief Information Officer	—
Mr. Howard Y. Chang M.D., Ph.D.	Senior VP of Global Research & Chief Scientific Officer	—

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-5.9	+12.0
2022	+0.2	-1.0	+7.4	-4.1	+11.2	-4.0	+0.8	-2.2	-8.2	+17.3	+5.3	-8.1
2023	-3.5	-6.0	+2.4	-1.9	-7.6	+3.6	+4.1	+10.4	+4.7	-4.0	+3.4	+5.7
2024	+5.7	-15.6	+1.4	-3.2	+10.3	+1.6	+6.9	-0.5	-2.5	-0.0	-11.4	-6.3
2025	+10.1	+6.6	+0.2	-5.2	+1.6	-3.2	+1.6	-3.1	-1.6	-0.0	+16.6	-3.0
2026	+4.3	+12.6	-8.8	-2.0	+2.1	+10.0	+6.6	+13.5	-3.8	+14.4	+2.8

Stocks in the same sector

FAQ

Buying Amgen (AMGN) stock is now easy and instant through the Gotrade app.

Download the Gotrade app from the App Store or Google Play.
Create an account and complete KYC.
Make a deposit.
Search for the code "AMGN", then tap "Trade".
Tap the "Buy" button.
Enter the amount you want to buy. You have two options:
1. Buy AMGN by number of shares.
2. Buy fractional shares in dollars, starting from $1.
Swipe up to confirm your order, and you're done!

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Amgen from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Yes, Amgen regularly pays dividends to shareholders. Currently, the estimated dividend yield for AMGN is around 2.08% per year. On Gotrade, cash dividends will be automatically credited to your account balance (after taxes).

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB, or 8:30 PM to 3:00 AM WIB during Daylight Saving Time. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours.

Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

There's no single perfect answer, but common approaches include:

Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
Review revenue and earnings growth.
Check margins and cash flow.
Evaluate business outlook and the company's position within its industry.

You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply

Amgen (AMGN) Stock

Key stats

Compare with AMGN

Recent news

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

What Amgen (AMGN) Said on Its Q3 Earnings Call

What Amgen (AMGN) Said on Its Q3 Earnings Call

Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say

Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say

Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

SLS Stock Snaps 4-Day Slide As Retail Eyes ASH Abstracts — Fresh Filings Reveal Bigger Swiss, Arizona Pension Bets

What Amgen (AMGN) Said on Its Q3 Earnings Call

What Amgen (AMGN) Said on Its Q3 Earnings Call

Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say

Amgen (AMGN) Reports Q3 Earnings: What Key Metrics Have to Say

Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates

Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.

Amgen, Up 41% This Year, Is Broadly Outperforming Its Peers. Here's What Its Earnings Say.

Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?

Will These 5 Drug Bigwigs Surpass Q3 Earnings Forecasts?

Amgen Just Gave Its Shareholders Great News

Amgen Just Gave Its Shareholders Great News

Stocktwits Pharma Pulse: Biotech Beats The Broader Market — Novo, Pfizer And Moderna Earnings Up Next

Stocktwits Pharma Pulse: Biotech Beats The Broader Market — Novo, Pfizer And Moderna Earnings Up Next

Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know

Amgen (AMGN) Increases Despite Market Slip: Here's What You Need to Know

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Amgen (AMGN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

About Amgen

Key Executives

Fundamentals

Valuation

Profitability

Trading

Dividend

Technical indicators

Analyst views

Seasonality

Corporate actions

Upcoming

Past

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade